Salute e Benessere

Bios Health Group Unveils Bios Innovation Circle™

The Bios Innovation Circle™ is a dynamic venture studio and strategic hub designed to catalyze the growth of startups and growing biotech and life science companies in a cost-effective and equity-sparing manner. By leveraging this powerful network, the Bios Innovation Circle™ offers tailored solutions including an extensive network of investors and partners eager to support promising ventures from concept to commercialization. The Bios Innovation Circle™ is a dynamic venture studio and...

Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an…

®has been sold. PYLCLARI ®(INN: Piflufolastat ( 18 F) also known as ( 18F)-DCFPyL, is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical settings:Primary staging of patients with high-risk prostate cancer prior to initial curative therapyTo localize recurrence of prostate cancer in patients with a suspected recurrence based on increasing serum...

Virbac : Declaration of the number of shares and voting rights 03/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsMarch, 31 20248 458 000Gross total of voting rights :...

Global A.I. Healthcare Market Expected to Expand at CAGR of 36.4% From 2024 to…

Grand View Research continued: "The growing shortage of healthcare workforce drove the adoption of AI/ML technologies. Therefore, AI algorithms can be trained to analyze patient health information, which further supports care providers in quickly diagnosing the condition and devising an accurate treatment regime. Supportive government initiatives, rising number of mergers and acquisitions and technological collaborations, and COVID-19 pandemic had a significant role in boosting the growth…

Calliditas Therapeutics to Attend Conferences in April

World Orphan Drug Congress, Thursday, April 25, 2024, in Boston, MA. Maria Törnsén, President North America, will be moderating a panel, entitled "Partnering in the rare disease space - industry perspective". World Orphan Drug Congress,Thursday, April 25, 2024, inBoston, MA.Maria Törnsén, President North America, will be moderating a panel, entitled "Partnering in the rare disease space - industry perspective". LSX World Congress,Monday, April 29, 2024, inLondon. Maria...

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680…

— Dose-Dependent Effects and Pharmacodynamic Profile Support Advancement Into Planned Phase 2 Study — —Dose-Dependent Effects and Pharmacodynamic Profile Support Advancement Into Planned Phase 2 Study — DUBLIN,April 9, 2024/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a phase1b, proof-of-concept study evaluating ALKS 2680, the company's novel, investigational, oral...

Increasing Health Consciousness among Aging Population Worldwide to Surge…

Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19416 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19416 The burgeoning growth of the beauty and cosmetic industry has contributed significantly to the rising demand for hyaluronic acid supplements. Consumers increasingly prioritize skincare and invest in products that...

GESKE German Beauty Tech Debuts its First-Ever Star-Studded Global Campaign

With a goal of inspiring daily rituals and skincare habits that lead to long-term results, GESKE German Beauty Tech offers a range of accessible, tech-forward devices that deliver effective results. The brand leverages the power of AI to help users curate personalized skincare routines tailored to their skin's needs, through its free AI-led app. With a goal of inspiring daily rituals and skincare habits that lead to long-term results, GESKE German Beauty Tech offers a range of accessible,...

4 in 10 elderly excluded on the basis of their age from getting the best…

"Ageism is a global problem: one in two people around the world is moderately or highly ageist toward older people, with a really serious impact. It decreases physical and mental health and increases social isolation," says Alana Officer, head of the department on Demographic Change at WHO and of the Healthy Ageing campaign. "WHO is leading a global campaign to combat ageism and build a broad coalition so that we all work together to eliminate it." "Ageism is a global…

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S…

The novel PFA system delivers short-duration, high-energy electrical pulses to the cardiac tissue to destroy cells that cause irregular heart rhythms without using excess heat or cold. Previous FDA-approved ablation systems used heat or cold to destroy cells, which could damage surrounding tissue. The novel PFA system delivers short-duration, high-energy electrical pulses to the cardiac tissue to destroy cells that cause irregular heart rhythms without using excess heat or cold. Previous...

European Parliament Recognizes Essential Tremor as Official Disease in…

The Joint Declaration specifically calls for the following: The Joint Declaration specifically calls for the following: "While progress has been made in advancing healthcare equity in the European Union, there is still a long way ahead to ensure that individuals affected by essential tremor have equitable access to life-changing treatment options," explainsAlex Agius Saliba, co-chair of the European Parliament interest group on neurological diseases and co-organiser of the event...

Intrance Medical Systems Inc signs LOI purchase commitment for clinical trials…

This information was brought to you by Cision http://news.cision.com This information was brought to you by Cisionhttp://news.cision.com https://news.cision.com/tridentify-ab/r/intrance-medical-systems-inc-signs-loi-purchase-commitment-for-clinical-trials-with-parkinson-s-dise,c3958421 The following files are available for download: View original content:...

Immunovia successfully develops assays to measure targeted proteins for its…

As the next milestone in developing its next-generation test Immunovia, in collaboration with the company's research and development partner Proteomedix (an Onconetix company), has developed accurate and reliable assays to measure the most promising proteins identified in the discovery study to move forward to a model-development study. As the next milestone in developing its next-generation test Immunovia, in collaboration with the company's research and development partner Proteomedix (an...

Medit Unveils i900: The Next Evolution of Intraoral Scanners

"Our customer focus fuels our advancements," said Michael Lee, CTO. "The i900 is a testament to our pursuit of innovation, empowering dentists to redefine the standards of patient care and practice efficiency." "Our customer focus fuels our advancements," saidMichael Lee, CTO. "The i900 is a testament to our pursuit of innovation, empowering dentists to redefine the standards of patient care and practice efficiency." The Medit i900 features an innovative…

KIDRON Capital Assets Announces First Close of Women's Health VC Fund

Our investment reach extends across three key geographies—Europe, the USA, and Israel. KIDRON's portfolio encompasses a diverse array of sectors, including medical devices, diagnostics, digital health, therapeutics, and services. This strategic diversity ensures our ability to impact various facets of women's health while driving innovation, positive change, and outstanding returns for our investors. Our investment reach extends across three key geographies—Europe, theUSA, andIsrael...

Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung…

09.00 EEST / 08.00 CEST 09.00 EEST / 08.00 CEST HELSINKI , April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced a collaboration with PlusVitech, a biotechnology company developing treatments for cancer, to use Nanoform's state-of-the-art nanomedicine technology to repurpose the anti-nausea medicine aprepitant as a treatment for lung cancer. The development program will include nanoforming the current active...

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase…

The bio-inert design of the instrument features Waters MaxPeak HPS Technology applied to key internal components including the system flow path to reduce unwanted interactions from metal-adsorbing analytes. The system pairs with Waters QuanRecovery™ Vials and Plates, as well as MaxPeak Premier HPLC Columns with eConnect™ Column Tag Technology, allowing for more confident platform methods that eliminate the need for lengthy column conditioning and method development. The bio-inert design of…

EssilorLuxottica closes the acquisition of Washin to grow its optical retail…

EssilorLuxottica closes the acquisition of Washin to grow its optical retail presence in JapanComplementing its investment in 'made in Japan' manufacturing, the transaction confirms the Group's commitment to further elevate vision care in the regionCharenton-le-Pont, France (April 9, 2024)– Luxottica Japan, part of EssilorLuxottica, closed the acquisition of Washin Optical Co., Ltd., a Japanese optical retail player counting approximately 70 direct stores in the country with a...

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage…

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastomaFirst development-stage asset to be added to the Essential Pharma portfolioand second product within rare diseaseEgham, UK – 9 April 2024– Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic...

Basilea awarded CARB-X grant to develop recently acquired novel class of…

Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has been awarded a grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership dedicated to supporting the early development of antibacterial products. The grant award is to support...

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and…

The initiation report was published April 8, 2024. Stifel joins four other banks whose analysts cover ONWARD Medical, all of which maintain Buy ratings and Target Prices at substantial premiums to the current share price.“Stifel's initiation of coverage reflects the value they place on the strategic positioning of our brain-computer interface (BCI) platform as well as their strong confidence in our ability to achieve this year's milestones, which include the planned commercialization of...

OKYO Pharma to Reschedule Key Opinion Leader Event in Dry Eye Disease to May…

LONDON and NEW YORK, April08, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announces that it will be rescheduling a Key Opinion Leader (KOL) event...

HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by…

Key Takeaways from the HPV16+ Cancer Market Report Key Takeaways from the HPV16+ Cancer Market Report Discover which therapies are expected to grab the major HPV16+ cancer market share @HPV16+ Cancer Market Report HPV16+ Cancer Overview Human papillomavirus (HPV) is a widespread group of viruses known to cause various cancers, with HPV16 standing out as one of the most concerning types. HPV16+ cancers refer to cancers caused by the HPV16 strain, most notably cervical…

Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by…

Key Takeaways from the Giant-Cell Arteritis Market Report Key Takeaways from the Giant-Cell Arteritis Market Report Discover which therapies are expected to grab the major giant-cell arteritis market share @Giant-Cell Arteritis Market Report Giant-Cell Arteritis Overview Giant-cell arteritis falls under the category of large-vessel vasculitis, although it also affects medium and small arteries, notably the superficial temporal artery, which is why it's often called temporal arteritis...

Altri Comunicati